Hansa Biopharma interim report January-March 2024
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
Source: prnewswire.com
📰 Lead Nicer News
Lead Nicer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lead Nicer. Real-time updates on events, politics, business and more.
Hansa Biopharma half year report 2023 (1)
LUND, Sweden, July 20, 2023 /PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme...
Source: europapress.es
Hansa Biopharma half year report 2023
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
United States United Kingdom Prnewswire Hansa Biopharma Donato Spota Hansa Biopharma Matthew Shaulis
Source: prnewswire.com
Hansa Biopharma half year report 2023 (2)
LUND, Sweden, July 20, 2023 /PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme...
Source: europapress.es
Hansa Biopharma Year-end report January-December 2022
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
United States United Kingdom Hansa Biopharma Prnewswire Hansa Biopharma Stephanie Kenney Klaus Sindahl
Source: prnewswire.com